In 2014, Flor M. Munoz and colleagues published “Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial,” hereafter “Tdap Immunization During Pregnancy,” in the Journal of the American Medical Association. The authors conducted a study to determine how Tdap immunization affected the mother and infant’s immune response to the common childhood diseases tetanus, diphtheria, and pertussis. They found that Tdap immunization did not lead to an increased risk of adverse health events. Furthermore, maternal Tdap immunization provided the infant with protective levels of pertussis antibodies after delivery and did not affect the infant differently from the DTaP vaccination series, which is the version of Tdap for young children. The authors’ findings in “Tdap Immunization During Pregnancy” supported the United States Centers for Disease Control and Prevention’s, or CDC’s, recommendation for pregnant women to receive the Tdap vaccine to prevent disease in mother and infant.

In 2014, Flor M. Munoz and colleagues published “Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial,” hereafter “Tdap Immunization During Pregnancy,” in the Journal of the American Medical Association. The authors conducted a study to determine how Tdap immunization affected the mother and infant’s immune response to the common childhood diseases tetanus, diphtheria, and pertussis. They found that Tdap immunization did not lead to an increased risk of adverse health events. Furthermore, maternal Tdap immunization provided the infant with protective levels of pertussis antibodies after delivery and did not affect the infant differently from the DTaP vaccination series, which is the version of Tdap for young children. The authors’ findings in “Tdap Immunization During Pregnancy” supported the United States Centers for Disease Control and Prevention’s, or CDC’s, recommendation for pregnant women to receive the Tdap vaccine to prevent disease in mother and infant.

The current study examined heterogeneity in emerging adult children's routine and self-disclosure to parents using mixture modeling and explored predictors and outcomes associated with the patterns of disclosure. Participants consisted of 449 emerging adults (49% male, 68% European American, 65% college students, 33% single-parent families) who completed questionnaires every year across three waves (Mage at Time 1 = 18.4 years). Latent profile analyses suggested that large groups of emerging adults reported moderate levels of routine disclosure and low levels of self-disclosure to both mothers (79%) and fathers (36%), while other groups (20%) reported high levels of routine and self-disclosure to both parents. Profile membership was associated with predictors (parental autonomy granting, self-disclosure to friend, gender, family structure, college attendance) at Time 1 and outcomes (delinquency, depression, and prosocial behavior) at Time 3. Implications regarding the continued parent-child relationship and disclosure to parents in the third decade of life are discussed.